SPARC-Targeted ZnS/BSA Nanoparticles For Multi-Mechanistic Mitigation of Early Brain Injury after Subarachnoid Hemorrhage
ACS Applied Materials & Interfaces · 16.09.2026 · 18 (36) · 48756-48772
DOI: 10.1021/acsami.6c09755 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 04.09.2026. Verfasst von Xishu Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang050024, P.R. China. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Sulfides, Nanoparticles, Brain Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Health Commission of Hebei Province, Jiangsu Hengrui Medicine, Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Subarachnoid hemorrhage (SAH) remains a devastating stroke subtype with high morbidity and mortality, largely due to complex early brain injury (EBI) within the first 72 h involving cerebral vasospasm (CVS), oxidative stress, and neuroinflammation. Existing therapies such as nimodipine offer limited protection and fail to address multiple injury pathways. Here, we report a SPARC-targeted albumin-based zinc sulfide nanoparticle (ZnS/BSA NPs) designed for lesion-specific delivery and multi-mechanistic therapy for SAH. We demonstrate that SPARC is significantly upregulated in both human and rat SAH brains, enabling active targeting of injured vasculature and crossing the blood–brain barrier (BBB). ZnS/BSA NPs exhibit good colloidal stability in serum-containing medium and pH-responsive release of Zn2+ and H2S. Mechanistically, Zn2+ suppresses Ca2+ influx/CaMKII activation to alleviate CVS; H2S activates NRF2/HO-1 to scavenge reactive oxygen/nitrogen species (RONS) and inhibits NF-κB/NLRP3 signaling to shift microglia from M1 to M2 polarization. Additionally, the NPs inhibit Caspase-1/GSDMD-mediated pyroptosis in microglia and suppress both Caspase-1/GSDMD-mediated pyroptosis and Bax/Caspase-3-mediated apoptosis in neurons, thereby preserving BBB integrity and reducing brain edema. In a rat SAH model, ZnS/BSA NPs significantly improved learning, memory, and motor function, outperforming nimodipine. This work highlights SPARC as a viable druggable target and represents a “targeted, multi-mechanistic” nanotherapeutic paradigm for EBI after SAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang050024, P.R. China.
- College of Chemistry and Material Science, Testing and Analysis Center, Hebei Normal University, Shijiazhuang050024, P.R. China.
- Institute for Engineering Medicine, Kunming Medical University, Kunming, Yunnan650500, P.R. China.
ORCID-Profile: Yupeng Wang, Xiaofeng Sun
Förderung
- Health Commission of Hebei Province
- Jiangsu Hengrui Medicine
- Natural Science Foundation of Hebei Province
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Liu, X., Wang, L., Li, C., Chen, Y., Yang, J., Cheng, H., Yang, Y., Wang, W., Liu, H., Wang, Y., & Sun, X. (2026). SPARC-Targeted ZnS/BSA Nanoparticles For Multi-Mechanistic Mitigation of Early Brain Injury after Subarachnoid Hemorrhage. ACS Applied Materials & Interfaces, 18(36), 48756-48772. https://doi.org/10.1021/acsami.6c09755
Vancouver
Liu X, Wang L, Li C, Chen Y, Yang J, Cheng H, et al. SPARC-Targeted ZnS/BSA Nanoparticles For Multi-Mechanistic Mitigation of Early Brain Injury after Subarachnoid Hemorrhage. ACS Applied Materials & Interfaces. 2026;18(36):48756-48772. doi:10.1021/acsami.6c09755
BibTeX
@article{Liu2026,
author = {Liu, Xishu and Wang, Lina and Li, Chen and Chen, Yucheng and Yang, Jipeng and Cheng, Hongyang and Yang, Yue and Wang, Wei and Liu, Hongjiang and Wang, Yupeng and Sun, Xiaofeng},
title = {SPARC-Targeted ZnS/BSA Nanoparticles For Multi-Mechanistic Mitigation of Early Brain Injury after Subarachnoid Hemorrhage},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {36},
pages = {48756--48772},
doi = {10.1021/acsami.6c09755}
}
EUVIMED